This possible new role of Claudin-5 in breast cancer cell motility opens the door to future studies in which Claudin-5 and therefore TJ might switch from static structures to very dynamic ones, and offers an exciting glimpse into how modulation of transmembrane TJ proteins could be targeted in cancer metastasis. This evidence concerns the gene CLDN5 and breast carcinoma.